Ischemic stroke risk stratification in patients with permanent form of atrial fibrillation

Abstract


The work is devoted to the investigation of the role of hemodynamic and coagulation indicators in ischemic stroke risk stratification in patients with permanent form of atrial fibrillation. The study included 60 CHD patients with permanent form of atrial fibrillation. All patients were divided into two groups: the 1 group consisted of 30 patients of average risk of ischemic stroke, the 2 group consisted of 30 patients of high risk of ischemic stroke. The study found that indicators that are associated with risk of ischemic stroke was the level of left atrial appendage flow velocity (LAAFV), left ventricular ejection fraction (LVEF), SEC as well as the level of SFMC and fibrinogen. During the univariate analysis with the risk of ischemic stroke was associated the level of LAAFV (OR - 0,92), LVEF (OR - 0,9), SEC (OR - 2,5), fibrinogen (OR - 4,0) and SFMC (OR - 1,27), but during multivariate regression analysis of their significance in predicting risk of ischemic stroke retained only the level of LAAFV (OR - 0,92) and fibrinogen (OR - 4,0).

About the authors

A O Rubanenko

Email: neron@samtel.ru

References

  1. ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation // Circulation. - 2006. - № 114. - P. 265-267.
  2. Guidelines for the management of atrial fibrillation. The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC) // European Heart Journal. - 2010. - № 31 (19). - P. 2369-2429.
  3. Панченко Е.П., Кропачева Е.С. Профилактика тромбоэмболий у больных мерцательной аритмией / Е.П. Панченко, Е.С. Кропачева. - М.: ООО «Медицинское информационное агентство», 2007. - 144 с.
  4. В.И. Шевелев, С.Г. Канорский. Диагностические возможности чреспищеводной эхокардиографии в установлении ультразвуковых предикторов ишемического инсульта у больных с фибрилляцией предсердий (обзор литературы) // Вестник новых медицинских технологий. - 2009. - № 4. - С. 91-92.
  5. Novo G., Mansueto P., La Franca ML. et al. Risk factors, atrial fibrillation and thromboembolic events // Int Angiol. - 2008. - №27(5). - P. 433-438.
  6. Loffredo L., Violi F., Fimognari FL., Cangemi R. et al. The association between hyperhomocysteinemia and ischemic stroke in patients with non-valvular atrial fibrillation // Haematologica. - 2005. - № 90 (9). - P. 1205-1211.
  7. William M. Feinberg, MD; Lesly A. Pearce, MS; Robert G. et al. Markers of Thrombin and Platelet Activity in Patients With Atrial Fibrillation // Stroke. - 1999. - № 30. P. 2547-2553.
  8. Седов А.Н. Длительная профилактика тромбоэмболических осложнений варфарином в комплексной терапии фибрилляции предсердий. Седов А.Н. // Автореферат … дис. канд. мед. наук. Москва. - 2009. 25 с.
  9. Е.В. Сердечная, Т.А. Истомина, Л.А. Кульминская с соавт. Дополнительные маркеры риска тромбоэмболического инсульта у больных с фибрилляцией предсердий. // Экология человека. - 2006. - № 9. - С. 37-42.
  10. Зотова И.В. Предикторы образования тромба в левом предсердии у больных с персистирующей формой мерцательной аритмии. Зотова И.В. // Автореферат … дис. канд. мед. наук. Москва. - 2008. 24 с.
  11. Sadanaga T, Kohsaka S, Ogawa S. D-dimer levels in combination with clinical risk factors can effectively predict subsequent thromboembolic events in patients with atrial fibrillation during oral anticoagulant therapy. // Cardiology. - 2010. - №117(1). P. 31-36.

Statistics

Views

Abstract - 35

Cited-By


Article Metrics

Metrics Loading ...

PlumX

Dimensions

Refbacks

  • There are currently no refbacks.

Copyright (c) 2011 Rubanenko A.O.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies